Definitive Contract 75F40122C00184
Award Date
9/21/22
Potential Completion Date
12/31/24
Potential Value
$138K
Federal Agency
Food and Drug Administration
Awardee
Alliance Nctn Foundation
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,275,361.26 definitive cost-no-fee contract to Alliance Nctn Foundation, a non-profit organization and foundation, to conduct the "Integrating Clinical Trials and Real World Endpoints Data (ICAREDATA) Data Capture and Standardization Study". This contract, with a performance period ending on September 29, 2024, is part of the FDA's broader efforts to advance regulatory science and support public...
The Department of Health and Human Services Food and Drug Administration awarded a definitive, cost-no-fee contract to the Alliance Nctn Foundation, a non-profit organization, for the "Adverse Event Reporting in the Integrating Clinical Trials and Real World Endpoints Data (ICAREDATA) Initiative" with a potential value of $518,381.51. The contract, which does not have a set-aside designation, is for work to be performed in Chicago, Illinois and has a completion date of December 31,...
This is a Cost No Fee definitive contract awarded by the Food and Drug Administration (FDA) to the Arkansas Research Alliance, a non-profit organization, for "Scientific and Methodological Advancements in Liquid Biopsies to Further the Development of Lung Cancer-Based Precision Medicine." The contract has a ceiling value of $754,003.90 and a performance period ending March 31, 2019. This contract was not set aside for any particular socioeconomic program. The contract supports the...
This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian federal agency, to Alliance For Advancing Biomedical Research, a non-profit organization. The $2,000,000.00 contract is for a transition task order related to an FFRDC (Federally Funded Research and Development Center) contract, with a period of performance through August 7, 2025. The contract does not have a set-aside designation. Based on the agency and nature of the work, this contract award is...
This is a $33,638.48 fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to the Centre International De Recherche SUR LE Cancer (IARC), a non-profit organization, for an "International Collaboration for Cancer Classification and Research (IC3R)." The contract has a completion date of September 20, 2024 and does not have a set-aside designation. IARC, the prime contractor, is the specialized cancer research agency of the World Health Organization,...
This is a $12,500 firm fixed price purchase order awarded by the Office of Logistics and Acquisition Operations, a division within the Department of Health and Human Services National Institutes of Health, to the Research Data Alliance Foundation. The contract supports "research data alliance activities" for a one-year period ending on December 31, 2025. The Research Data Alliance Foundation is an international non-profit organization that specializes in supporting research data...
This federal contract award, valued at $347,762.49, was issued by the Food and Drug Administration (FDA) to Northwestern University to conduct research and development supporting the FDA's Oncology Center of Excellence's Patient-Focused Drug Development (PFDD) program. The contract is a definitive, cost-no-fee contract with an ultimate completion date of December 30, 2024. The original solicitation was a Broad Agency Announcement (BAA) seeking proposals across eight areas of regulatory science...
The Department of Health and Human Services Food and Drug Administration awarded a $24,998.00 firm fixed price purchase order to the non-profit National Council On Radiation Protection & Measurements (NCRP) to support the Center for Devices and Radiological Health (CDRH) in advancing FDA efforts to work with manufacturers to develop radiation therapy devices that incorporate principles of safety by design. The award has no set-aside designation and was made on September 10, 2021 with a...
This is a $4,456,062.35 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for support to conduct 10 post-market safety studies, with a period of performance through August 29, 2025. ICA has an extensive track record of delivering a wide range of healthcare IT, data analytics, and management consulting services to federal...